文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

24小时后缓解与确认的ARDS:LUNG SAFE研究的启示

Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study.
PubMed 文献 · Intensive Care Med · 2018-04-09
一句话结论24小时后仍符合ARDS定义者住院死亡率41%,确认的重度ARDS第2天死亡率57%,而第2天重新分类对死亡预测价值有限。

该研究为LUNG SAFE二次分析,纳入2377例第1天符合ARDS定义并接受有创机械通气的患者,比较24小时后ARDS缓解与确认者的结局。503例(24%)第2天不再符合ARDS定义,其中52%初始为中重度ARDS。总体住院死亡率38%,缓解组31%,确认组41%,第2天确认的重度ARDS达57%。第1天较高潮气量与ARDS确认相关(OR 1.07,CI 1.01-1.13,P=0.035)。第2天ARDS重新分类对死亡预测的AUC提升有限。

要点

  • 2377例第1天符合ARDS定义且接受有创机械通气的患者中,503例(24%)第2天不再符合ARDS定义。
  • 住院死亡率总体38%,缓解ARDS组31%,确认ARDS组41%,第2天确认的重度ARDS组57%。
  • 第1天较高潮气量与ARDS确认相关(OR 1.07,CI 1.01-1.13,P=0.035)。
  • 缓解与确认ARDS中,年龄、非呼吸SOFA评分、较低PEEP和P/F比、较高峰值压力和呼吸频率均与死亡率相关。
  • 确认ARDS中,pH及存在免疫抑制或肿瘤亦与死亡率相关;第2天重新分类对死亡预测的AUC提升有限。

适用人群与场景

  • 第1天符合ARDS定义并接受有创机械通气的患者(LUNG SAFE研究人群)。

诊断标准与关键阈值

  • ARDS定义:第1天符合ARDS定义且接受有创机械通气;第2天重新评估是否符合ARDS定义以分为缓解与确认。

研究设计与关键结果

  • 研究类型:LUNG SAFE研究的二次分析;样本量2377例第1天符合ARDS定义并接受有创机械通气的患者。
  • 第2天503例(24%)不再符合ARDS定义(缓解),其中52%初始为中重度ARDS。
  • 住院死亡率总体38%,缓解ARDS组31%,确认ARDS组41%,第2天确认的重度ARDS组57%。
  • 第1天较高潮气量与ARDS确认相关(OR 1.07,CI 1.01-1.13,P=0.035)。
  • 缓解与确认ARDS中,年龄、非呼吸SOFA评分、较低PEEP和P/F比、较高峰值压力和呼吸频率均与死亡率相关。
  • 确认ARDS中,pH及存在免疫抑制或肿瘤亦与死亡率相关。
  • 第2天ARDS重新分类对死亡预测的AUC提升有限。

证据类型、等级与局限

  • 证据类型:LUNG SAFE研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • ARDS无论第2天缓解或确认,死亡率均高;第2天重新分类对死亡预测价值有限,作者认为重度确认ARDS死亡风险高,复杂干预可能最适合在该人群中测试。

指南或共识出处

  • LUNG SAFE研究(ClinicalTrials.gov NCT02010073)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To evaluate patients with resolved versus confirmed ARDS, identify subgroups with substantial mortality risk, and to determine the utility of day 2 ARDS reclassification.

METHODS: Our primary objective, in this secondary LUNG SAFE analysis, was to compare outcome in patients with resolved versus confirmed ARDS after 24 h. Secondary objectives included identifying factors associated with ARDS persistence and mortality, and the utility of day 2 ARDS reclassification.

RESULTS: Of 2377 patients fulfilling the ARDS definition on the first day of ARDS (day 1) and receiving invasive mechanical ventilation, 503 (24%) no longer fulfilled the ARDS definition the next day, 52% of whom initially had moderate or severe ARDS. Higher tidal volume on day 1 of ARDS was associated with confirmed ARDS [OR 1.07 (CI 1.01-1.13), P = 0.035]. Hospital mortality was 38% overall, ranging from 31% in resolved ARDS to 41% in confirmed ARDS, and 57% in confirmed severe ARDS at day 2. In both resolved and confirmed ARDS, age, non-respiratory SOFA score, lower PEEP and P/F ratio, higher peak pressure and respiratory rate were each associated with mortality. In confirmed ARDS, pH and the presence of immunosuppression or neoplasm were also associated with mortality. The increase in area under the receiver operating curve for ARDS reclassification on day 2 was marginal.

CONCLUSIONS: ARDS, whether resolved or confirmed at day 2, has a high mortality rate. ARDS reclassification at day 2 has limited predictive value for mortality. The substantial mortality risk in severe confirmed ARDS suggests that complex interventions might best be tested in this population.

TRIAL REGISTRATION: ClinicalTrials.gov NCT02010073.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Madotto F, Pham T, Bellani G, et al. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study. Intensive Care Med. 2018. PMID: 29632996. doi:10.1007/s00134-018-5152-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。